NCT04336995CompletedPhase 4
Exercise Pulmonary Transit Time
Echocardiographic Assessment of Pulmonary Transit Time Following Exercise
Source: ClinicalTrials.gov · Last updated 9 Apr 2024
Brief summary (registry, in English)
The study seeks to measure pulmonary transit time via contrast-echocardiography before and after exercise.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 14 (actual)
- First submitted
- 3 Apr 2020
- Start date
- 27 Aug 2020
- Primary completion date
- 25 Aug 2021
- Lead sponsor
- Vanderbilt University Medical Center
- Diseases
- Heart failure
- NCT number
- NCT04336995
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 14
- From 27 Aug 2020 to the primary completion date, 25 Aug 2021
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known allergic reaction to Definity or Optison ultrasound contrast
Other
- Pregnancy/Nursing - as assessed/disclosed by the participant
Who the study is looking for
- Age ≥ 18 years old
- Able to give informed consent
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| VHVI Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.